Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Its molecular structure and proposed mechanisms of action are what make it so intriguing to the scientific community
& Schadt, J
Across 12 major markets, drug spending has remained a consistent share of total healthcare costs, averaging around 15 percent
What are the optimal drug characteristics of a GLP-1/glucagon co-agonist for the treatment of NAFLD via hepatic GCGR agonism
"GLP-1s blow way past that threshold, even at lower numbers of uptake." A common argument for GLP-1 coverage is that its use could be a preventive measure that leads to long-term savings
Methods A systematic literature search was conducted in PubMed, Web of Science, and Scopus until October 2022
US$ 28.07
US$ 29.38
US$ 27.08
US$ 25.20
US$ 21.56
US$ 28.53
